JPMorgan Says Omicron Won’t Stop the Global Equities Rally_老虎社区_美港股上老虎

JPMorgan Says Omicron Won’t Stop the Global Equities Rally

Bloomberg2021-11-30

Strategists expect post-Covid normalization to assert itself See 9% upside for S&P 500 by end-2022; 17% for Eurozone stocks Omicron won’t derail the rally for global stocks, according to JPMorgan ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

PearlynCSY
·2021-12-01
Yesterday, Moderna CEO says vaccines likely no match for Omicron variant. And that it could take months to develop and ship an omicron specific vaccine, but a higher dose of its booster could be ready much sooner.
回复
1
举报
Troytan
·2021-11-30
It’s a matter of time that we co exist with whatever Covid 19 variants. Life goes on.
回复
1
举报
YCTye
·2021-11-30
Hmm.. really?
回复
点赞
举报
Jen88
·2021-11-30
Ok
回复
4
举报
收起
- ponyinvestor:
  Like and comment pls
  2021-11-30
  回复
  举报
lyokel
·2021-11-30
Ok
回复
4
举报
收起
- Jen88:
  Ok
  2021-11-30
  回复
  举报
- Fumiyo:
  ok
  2021-11-30
  回复
  举报
Catchua
·2021-11-30
Good
回复
3
举报
收起
- MrTig3r:
  power
  2021-11-30
  回复
  举报
- lyokel:
  🙏
  2021-11-30
  回复
  举报
aprilialand
·2021-11-30
sure anot
回复
5
举报
收起
- aprilialand:
  following
  2021-11-30
  回复
  举报
Mccoy
·2021-11-30
Really?
回复
4
举报
Hk01
·2021-11-30
Cool
回复
1
举报
PrimeBlue
·2021-11-30
Given a better understanding of the virus, there should not be as widespread lockdowns expected.Any negative news should prove to be good opportunity for swing traders
回复
2
举报
收起
- wyin08:
  yup
  2021-11-30
  回复
  举报
miaomee
·2021-11-30
Buy
回复
2
举报
KLS
·2021-11-30
Buy
回复
3
举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2187581396?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-11-30 20:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2187581396","market":"us","top_or_hot":-1,"title":"JPMorgan Says Omicron Won’t Stop the Global Equities Rally","media":"Bloomberg","content":"<div>\n<p>Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; 17% for Eurozone stocks\n\nOmicron won’t derail the rally for global stocks, according to JPMorgan ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally\">网页链接</a>\n\n</div>\n","source":"lsy1584095487587","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JPMorgan Says Omicron Won’t Stop the Global Equities Rally</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJPMorgan Says Omicron Won’t Stop the Global Equities Rally\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 20:18 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; 17% for Eurozone stocks\n\nOmicron won’t derail the rally for global stocks, according to JPMorgan ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":".IXIC","symbol_name":"NASDAQ Composite","start_time":0,"source_url":"https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally","article_id":"2187581396","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2187581396","pubTimestamp":1638274712,"columns":[],"sourceInfo":{"source_id":"lsy1584095487587","name":"Bloomberg"},"weMediaInfo":null,"summary":"Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; ","collect":0,"end_time":0,"defaultTopTitle":"bloomberg.com","property":[],"viewcount":null,"language":"en","relate_stocks":{".IXIC":"NASDAQ Composite","BK4534":"瑞士信贷持仓","BK4550":"红杉资本持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4504":"桥水持仓",".SPX":"S&P 500 Index",".DJI":"道琼斯","BK4566":"资本集团","BK4207":"综合性银行","MRNA":"Moderna, Inc.","JPM":"摩根大通"},"translate_title":"摩根大通称Omicron不会阻止全球股市反弹","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"JPM":0.9,"MRNA":0.9},"content_text":"Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; 17% for Eurozone stocks\n\nOmicron won’t derail the rally for global stocks, according to JPMorgan Chase & Co. strategists, adding another voice to the tone of cautious optimism in the market after the recent sharp pullback.\n“Sporadic setbacks,” such as the emergence of omicron should be viewed “in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,” strategists led by Dubravko Lakos-Bujas and Mislav Matejka wrote in a note. “We expect post-Covid normalization to continue to assert itself globally in 2022,” they said.\nEuropean and Asian stocks, along with U.S. equity futures, fell on Tuesday after Moderna Inc. executives confirmed that the omicron coronavirus variant could evade existing vaccines. Research is still underway to determine if the new strain is as virulent as its predecessors, while developers including Moderna, Pfizer Inc. and BioNTech SE are working on potentially updated versions of their shots.\n\nUnfazed by the latest scare, JPMorgan’s strategists forecast that the S&P 500 Index will gain about 9% from its current levels to climb to 5,050 by end-2022. “We continue to see market upside, though more moderate, on better-than-expected earnings growth with supply shocks easing, China/EM backdrop improving, and normalizing consumer spending habits,” they wrote in their year-ahead outlook note.\nThe strategists expect European equities to outperform U.S., Chinese stocks to fare better than emerging markets, and emerging markets to outpace developed ones.\nThey singled out a hawkish shift by central banks, rather than Covid-19, as the key risk to their bullish outlook, while recommending that investors retain a pro-cyclical tilt, with a preference for energy and financials, consumer services, and small caps. They favor healthcare over other defensive sectors.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":609553626,"gmtCreate":1638312549710,"gmtModify":1638312549923,"author":{"id":"4092458811577680","authorId":"4092458811577680","name":"PearlynCSY","avatar":"https://static.tigerbbs.com/b3e9fe7af061efe80a756d23de62e7b3","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"4092458811577680","authorIdStr":"4092458811577680"},"htmlText":"Yesterday, Moderna CEO says vaccines likely no match for Omicron variant. And that it could take months to develop and ship an omicron specific vaccine, but a higher dose of its booster could be ready much sooner.","listText":"Yesterday, Moderna CEO says vaccines likely no match for Omicron variant. And that it could take months to develop and ship an omicron specific vaccine, but a higher dose of its booster could be ready much sooner.","text":"Yesterday, Moderna CEO says vaccines likely no match for Omicron variant. And that it could take months to develop and ship an omicron specific vaccine, but a higher dose of its booster could be ready much sooner.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609553626","repostId":2187581396,"repostType":4,"repost":{"id":"2187581396","kind":"news","pubTimestamp":1638274712,"share":"https://www.laohu8.com/m/news/2187581396?lang=&edition=full","pubTime":"2021-11-30 20:18","market":"us","language":"en","title":"JPMorgan Says Omicron Won’t Stop the Global Equities Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=2187581396","media":"Bloomberg","summary":"Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; ","content":"<ul>\n <li>Strategists expect post-Covid normalization to assert itself</li>\n <li>See 9% upside for S&amp;P 500 by end-2022; 17% for Eurozone stocks</li>\n</ul>\n<p>Omicron won’t derail the rally for global stocks, according to JPMorgan Chase &amp; Co. strategists, adding another voice to the tone of&nbsp;cautious optimism&nbsp;in the market after the recent sharp pullback.</p>\n<p>“Sporadic setbacks,” such as the emergence of omicron should be viewed “in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,” strategists led by Dubravko Lakos-Bujas and Mislav Matejka wrote in a note. “We expect post-Covid normalization to continue to assert itself globally in 2022,” they said.</p>\n<p>European and Asian stocks, along with U.S. equity futures, fell on Tuesday after&nbsp;Moderna Inc.&nbsp;executives confirmed that the omicron coronavirus variant&nbsp;could evade existing vaccines. Research is still underway to determine if the new strain is as virulent as its predecessors, while developers including Moderna, Pfizer Inc. and BioNTech SE are working on potentially updated versions of their shots.</p>\n<p><img src=\"https://static.tigerbbs.com/9fb3f6e11f7c305d036b47b9ae9eb2e5\" tg-width=\"889\" tg-height=\"501\" width=\"100%\" height=\"auto\"></p>\n<p>Unfazed by the latest scare, JPMorgan’s strategists forecast that the S&amp;P 500 Index will gain about 9% from its current levels to climb to 5,050 by end-2022. “We continue to see market upside, though more moderate, on better-than-expected earnings growth with supply shocks easing, China/EM backdrop improving, and normalizing consumer spending habits,” they wrote in their year-ahead outlook note.</p>\n<p>The strategists expect European equities to outperform U.S., Chinese stocks to fare better than emerging markets, and emerging markets to outpace developed ones.</p>\n<p>They singled out a hawkish shift by central banks, rather than Covid-19, as the key risk to their bullish outlook, while recommending that investors retain a pro-cyclical tilt, with a preference for energy and financials, consumer services, and small caps. They favor healthcare over other defensive sectors.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JPMorgan Says Omicron Won’t Stop the Global Equities Rally</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJPMorgan Says Omicron Won’t Stop the Global Equities Rally\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 20:18 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; 17% for Eurozone stocks\n\nOmicron won’t derail the rally for global stocks, according to JPMorgan ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4207":"综合性银行",".DJI":"道琼斯","BK4534":"瑞士信贷持仓","MRNA":"Moderna, Inc.",".IXIC":"NASDAQ Composite","JPM":"摩根大通",".SPX":"S&P 500 Index","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","BK4504":"桥水持仓","BK4566":"资本集团"},"source_url":"https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2187581396","content_text":"Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; 17% for Eurozone stocks\n\nOmicron won’t derail the rally for global stocks, according to JPMorgan Chase & Co. strategists, adding another voice to the tone of cautious optimism in the market after the recent sharp pullback.\n“Sporadic setbacks,” such as the emergence of omicron should be viewed “in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,” strategists led by Dubravko Lakos-Bujas and Mislav Matejka wrote in a note. “We expect post-Covid normalization to continue to assert itself globally in 2022,” they said.\nEuropean and Asian stocks, along with U.S. equity futures, fell on Tuesday after Moderna Inc. executives confirmed that the omicron coronavirus variant could evade existing vaccines. Research is still underway to determine if the new strain is as virulent as its predecessors, while developers including Moderna, Pfizer Inc. and BioNTech SE are working on potentially updated versions of their shots.\n\nUnfazed by the latest scare, JPMorgan’s strategists forecast that the S&P 500 Index will gain about 9% from its current levels to climb to 5,050 by end-2022. “We continue to see market upside, though more moderate, on better-than-expected earnings growth with supply shocks easing, China/EM backdrop improving, and normalizing consumer spending habits,” they wrote in their year-ahead outlook note.\nThe strategists expect European equities to outperform U.S., Chinese stocks to fare better than emerging markets, and emerging markets to outpace developed ones.\nThey singled out a hawkish shift by central banks, rather than Covid-19, as the key risk to their bullish outlook, while recommending that investors retain a pro-cyclical tilt, with a preference for energy and financials, consumer services, and small caps. They favor healthcare over other defensive sectors.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":609203222,"gmtCreate":1638283856037,"gmtModify":1638284163738,"author":{"id":"3571482048865852","authorId":"3571482048865852","name":"Troytan","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3571482048865852","authorIdStr":"3571482048865852"},"htmlText":"It’s a matter of time that&nbsp;we co exist with &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; whatever&nbsp;Covid 19 variants. Life goes on.","listText":"It’s a matter of time that&nbsp;we co exist with &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; whatever&nbsp;Covid 19 variants. Life goes on.","text":"It’s a matter of time that we co exist with whatever Covid 19 variants. Life goes on.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609203222","repostId":2187581396,"repostType":4,"repost":{"id":"2187581396","kind":"news","pubTimestamp":1638274712,"share":"https://www.laohu8.com/m/news/2187581396?lang=&edition=full","pubTime":"2021-11-30 20:18","market":"us","language":"en","title":"JPMorgan Says Omicron Won’t Stop the Global Equities Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=2187581396","media":"Bloomberg","summary":"Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; ","content":"<ul>\n <li>Strategists expect post-Covid normalization to assert itself</li>\n <li>See 9% upside for S&amp;P 500 by end-2022; 17% for Eurozone stocks</li>\n</ul>\n<p>Omicron won’t derail the rally for global stocks, according to JPMorgan Chase &amp; Co. strategists, adding another voice to the tone of&nbsp;cautious optimism&nbsp;in the market after the recent sharp pullback.</p>\n<p>“Sporadic setbacks,” such as the emergence of omicron should be viewed “in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,” strategists led by Dubravko Lakos-Bujas and Mislav Matejka wrote in a note. “We expect post-Covid normalization to continue to assert itself globally in 2022,” they said.</p>\n<p>European and Asian stocks, along with U.S. equity futures, fell on Tuesday after&nbsp;Moderna Inc.&nbsp;executives confirmed that the omicron coronavirus variant&nbsp;could evade existing vaccines. Research is still underway to determine if the new strain is as virulent as its predecessors, while developers including Moderna, Pfizer Inc. and BioNTech SE are working on potentially updated versions of their shots.</p>\n<p><img src=\"https://static.tigerbbs.com/9fb3f6e11f7c305d036b47b9ae9eb2e5\" tg-width=\"889\" tg-height=\"501\" width=\"100%\" height=\"auto\"></p>\n<p>Unfazed by the latest scare, JPMorgan’s strategists forecast that the S&amp;P 500 Index will gain about 9% from its current levels to climb to 5,050 by end-2022. “We continue to see market upside, though more moderate, on better-than-expected earnings growth with supply shocks easing, China/EM backdrop improving, and normalizing consumer spending habits,” they wrote in their year-ahead outlook note.</p>\n<p>The strategists expect European equities to outperform U.S., Chinese stocks to fare better than emerging markets, and emerging markets to outpace developed ones.</p>\n<p>They singled out a hawkish shift by central banks, rather than Covid-19, as the key risk to their bullish outlook, while recommending that investors retain a pro-cyclical tilt, with a preference for energy and financials, consumer services, and small caps. They favor healthcare over other defensive sectors.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JPMorgan Says Omicron Won’t Stop the Global Equities Rally</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJPMorgan Says Omicron Won’t Stop the Global Equities Rally\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 20:18 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; 17% for Eurozone stocks\n\nOmicron won’t derail the rally for global stocks, according to JPMorgan ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4207":"综合性银行",".DJI":"道琼斯","BK4534":"瑞士信贷持仓","MRNA":"Moderna, Inc.",".IXIC":"NASDAQ Composite","JPM":"摩根大通",".SPX":"S&P 500 Index","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","BK4504":"桥水持仓","BK4566":"资本集团"},"source_url":"https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2187581396","content_text":"Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; 17% for Eurozone stocks\n\nOmicron won’t derail the rally for global stocks, according to JPMorgan Chase & Co. strategists, adding another voice to the tone of cautious optimism in the market after the recent sharp pullback.\n“Sporadic setbacks,” such as the emergence of omicron should be viewed “in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,” strategists led by Dubravko Lakos-Bujas and Mislav Matejka wrote in a note. “We expect post-Covid normalization to continue to assert itself globally in 2022,” they said.\nEuropean and Asian stocks, along with U.S. equity futures, fell on Tuesday after Moderna Inc. executives confirmed that the omicron coronavirus variant could evade existing vaccines. Research is still underway to determine if the new strain is as virulent as its predecessors, while developers including Moderna, Pfizer Inc. and BioNTech SE are working on potentially updated versions of their shots.\n\nUnfazed by the latest scare, JPMorgan’s strategists forecast that the S&P 500 Index will gain about 9% from its current levels to climb to 5,050 by end-2022. “We continue to see market upside, though more moderate, on better-than-expected earnings growth with supply shocks easing, China/EM backdrop improving, and normalizing consumer spending habits,” they wrote in their year-ahead outlook note.\nThe strategists expect European equities to outperform U.S., Chinese stocks to fare better than emerging markets, and emerging markets to outpace developed ones.\nThey singled out a hawkish shift by central banks, rather than Covid-19, as the key risk to their bullish outlook, while recommending that investors retain a pro-cyclical tilt, with a preference for energy and financials, consumer services, and small caps. They favor healthcare over other defensive sectors.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":609679588,"gmtCreate":1638283228983,"gmtModify":1638283228983,"author":{"id":"3586379608407775","authorId":"3586379608407775","name":"YCTye","avatar":"https://static.tigerbbs.com/e92a775162442ad5f515908ebbc21971","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3586379608407775","authorIdStr":"3586379608407775"},"htmlText":"Hmm.. really?","listText":"Hmm.. really?","text":"Hmm.. really?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609679588","repostId":2187581396,"repostType":4,"repost":{"id":"2187581396","kind":"news","pubTimestamp":1638274712,"share":"https://www.laohu8.com/m/news/2187581396?lang=&edition=full","pubTime":"2021-11-30 20:18","market":"us","language":"en","title":"JPMorgan Says Omicron Won’t Stop the Global Equities Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=2187581396","media":"Bloomberg","summary":"Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; ","content":"<ul>\n <li>Strategists expect post-Covid normalization to assert itself</li>\n <li>See 9% upside for S&amp;P 500 by end-2022; 17% for Eurozone stocks</li>\n</ul>\n<p>Omicron won’t derail the rally for global stocks, according to JPMorgan Chase &amp; Co. strategists, adding another voice to the tone of&nbsp;cautious optimism&nbsp;in the market after the recent sharp pullback.</p>\n<p>“Sporadic setbacks,” such as the emergence of omicron should be viewed “in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,” strategists led by Dubravko Lakos-Bujas and Mislav Matejka wrote in a note. “We expect post-Covid normalization to continue to assert itself globally in 2022,” they said.</p>\n<p>European and Asian stocks, along with U.S. equity futures, fell on Tuesday after&nbsp;Moderna Inc.&nbsp;executives confirmed that the omicron coronavirus variant&nbsp;could evade existing vaccines. Research is still underway to determine if the new strain is as virulent as its predecessors, while developers including Moderna, Pfizer Inc. and BioNTech SE are working on potentially updated versions of their shots.</p>\n<p><img src=\"https://static.tigerbbs.com/9fb3f6e11f7c305d036b47b9ae9eb2e5\" tg-width=\"889\" tg-height=\"501\" width=\"100%\" height=\"auto\"></p>\n<p>Unfazed by the latest scare, JPMorgan’s strategists forecast that the S&amp;P 500 Index will gain about 9% from its current levels to climb to 5,050 by end-2022. “We continue to see market upside, though more moderate, on better-than-expected earnings growth with supply shocks easing, China/EM backdrop improving, and normalizing consumer spending habits,” they wrote in their year-ahead outlook note.</p>\n<p>The strategists expect European equities to outperform U.S., Chinese stocks to fare better than emerging markets, and emerging markets to outpace developed ones.</p>\n<p>They singled out a hawkish shift by central banks, rather than Covid-19, as the key risk to their bullish outlook, while recommending that investors retain a pro-cyclical tilt, with a preference for energy and financials, consumer services, and small caps. They favor healthcare over other defensive sectors.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JPMorgan Says Omicron Won’t Stop the Global Equities Rally</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJPMorgan Says Omicron Won’t Stop the Global Equities Rally\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 20:18 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; 17% for Eurozone stocks\n\nOmicron won’t derail the rally for global stocks, according to JPMorgan ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4207":"综合性银行",".DJI":"道琼斯","BK4534":"瑞士信贷持仓","MRNA":"Moderna, Inc.",".IXIC":"NASDAQ Composite","JPM":"摩根大通",".SPX":"S&P 500 Index","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","BK4504":"桥水持仓","BK4566":"资本集团"},"source_url":"https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2187581396","content_text":"Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; 17% for Eurozone stocks\n\nOmicron won’t derail the rally for global stocks, according to JPMorgan Chase & Co. strategists, adding another voice to the tone of cautious optimism in the market after the recent sharp pullback.\n“Sporadic setbacks,” such as the emergence of omicron should be viewed “in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,” strategists led by Dubravko Lakos-Bujas and Mislav Matejka wrote in a note. “We expect post-Covid normalization to continue to assert itself globally in 2022,” they said.\nEuropean and Asian stocks, along with U.S. equity futures, fell on Tuesday after Moderna Inc. executives confirmed that the omicron coronavirus variant could evade existing vaccines. Research is still underway to determine if the new strain is as virulent as its predecessors, while developers including Moderna, Pfizer Inc. and BioNTech SE are working on potentially updated versions of their shots.\n\nUnfazed by the latest scare, JPMorgan’s strategists forecast that the S&P 500 Index will gain about 9% from its current levels to climb to 5,050 by end-2022. “We continue to see market upside, though more moderate, on better-than-expected earnings growth with supply shocks easing, China/EM backdrop improving, and normalizing consumer spending habits,” they wrote in their year-ahead outlook note.\nThe strategists expect European equities to outperform U.S., Chinese stocks to fare better than emerging markets, and emerging markets to outpace developed ones.\nThey singled out a hawkish shift by central banks, rather than Covid-19, as the key risk to their bullish outlook, while recommending that investors retain a pro-cyclical tilt, with a preference for energy and financials, consumer services, and small caps. They favor healthcare over other defensive sectors.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":609618245,"gmtCreate":1638278026537,"gmtModify":1638278026655,"author":{"id":"3582993517958198","authorId":"3582993517958198","name":"Jen88","avatar":"https://static.tigerbbs.com/5aaf732b230f1241c2c9b76b2b27ae00","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3582993517958198","authorIdStr":"3582993517958198"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/609618245","repostId":2187581396,"repostType":4,"repost":{"id":"2187581396","kind":"news","pubTimestamp":1638274712,"share":"https://www.laohu8.com/m/news/2187581396?lang=&edition=full","pubTime":"2021-11-30 20:18","market":"us","language":"en","title":"JPMorgan Says Omicron Won’t Stop the Global Equities Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=2187581396","media":"Bloomberg","summary":"Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; ","content":"<ul>\n <li>Strategists expect post-Covid normalization to assert itself</li>\n <li>See 9% upside for S&amp;P 500 by end-2022; 17% for Eurozone stocks</li>\n</ul>\n<p>Omicron won’t derail the rally for global stocks, according to JPMorgan Chase &amp; Co. strategists, adding another voice to the tone of&nbsp;cautious optimism&nbsp;in the market after the recent sharp pullback.</p>\n<p>“Sporadic setbacks,” such as the emergence of omicron should be viewed “in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,” strategists led by Dubravko Lakos-Bujas and Mislav Matejka wrote in a note. “We expect post-Covid normalization to continue to assert itself globally in 2022,” they said.</p>\n<p>European and Asian stocks, along with U.S. equity futures, fell on Tuesday after&nbsp;Moderna Inc.&nbsp;executives confirmed that the omicron coronavirus variant&nbsp;could evade existing vaccines. Research is still underway to determine if the new strain is as virulent as its predecessors, while developers including Moderna, Pfizer Inc. and BioNTech SE are working on potentially updated versions of their shots.</p>\n<p><img src=\"https://static.tigerbbs.com/9fb3f6e11f7c305d036b47b9ae9eb2e5\" tg-width=\"889\" tg-height=\"501\" width=\"100%\" height=\"auto\"></p>\n<p>Unfazed by the latest scare, JPMorgan’s strategists forecast that the S&amp;P 500 Index will gain about 9% from its current levels to climb to 5,050 by end-2022. “We continue to see market upside, though more moderate, on better-than-expected earnings growth with supply shocks easing, China/EM backdrop improving, and normalizing consumer spending habits,” they wrote in their year-ahead outlook note.</p>\n<p>The strategists expect European equities to outperform U.S., Chinese stocks to fare better than emerging markets, and emerging markets to outpace developed ones.</p>\n<p>They singled out a hawkish shift by central banks, rather than Covid-19, as the key risk to their bullish outlook, while recommending that investors retain a pro-cyclical tilt, with a preference for energy and financials, consumer services, and small caps. They favor healthcare over other defensive sectors.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JPMorgan Says Omicron Won’t Stop the Global Equities Rally</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJPMorgan Says Omicron Won’t Stop the Global Equities Rally\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 20:18 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; 17% for Eurozone stocks\n\nOmicron won’t derail the rally for global stocks, according to JPMorgan ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4207":"综合性银行",".DJI":"道琼斯","BK4534":"瑞士信贷持仓","MRNA":"Moderna, Inc.",".IXIC":"NASDAQ Composite","JPM":"摩根大通",".SPX":"S&P 500 Index","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","BK4504":"桥水持仓","BK4566":"资本集团"},"source_url":"https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2187581396","content_text":"Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; 17% for Eurozone stocks\n\nOmicron won’t derail the rally for global stocks, according to JPMorgan Chase & Co. strategists, adding another voice to the tone of cautious optimism in the market after the recent sharp pullback.\n“Sporadic setbacks,” such as the emergence of omicron should be viewed “in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,” strategists led by Dubravko Lakos-Bujas and Mislav Matejka wrote in a note. “We expect post-Covid normalization to continue to assert itself globally in 2022,” they said.\nEuropean and Asian stocks, along with U.S. equity futures, fell on Tuesday after Moderna Inc. executives confirmed that the omicron coronavirus variant could evade existing vaccines. Research is still underway to determine if the new strain is as virulent as its predecessors, while developers including Moderna, Pfizer Inc. and BioNTech SE are working on potentially updated versions of their shots.\n\nUnfazed by the latest scare, JPMorgan’s strategists forecast that the S&P 500 Index will gain about 9% from its current levels to climb to 5,050 by end-2022. “We continue to see market upside, though more moderate, on better-than-expected earnings growth with supply shocks easing, China/EM backdrop improving, and normalizing consumer spending habits,” they wrote in their year-ahead outlook note.\nThe strategists expect European equities to outperform U.S., Chinese stocks to fare better than emerging markets, and emerging markets to outpace developed ones.\nThey singled out a hawkish shift by central banks, rather than Covid-19, as the key risk to their bullish outlook, while recommending that investors retain a pro-cyclical tilt, with a preference for energy and financials, consumer services, and small caps. They favor healthcare over other defensive sectors.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6785485,"gmtCreate":1638279387485,"gmtModify":1638279387518,"authorId":3575443999456708,"author":{"id":3575443999456708,"idStr":"3575443999456708","authorId":3575443999456708,"name":"ponyinvestor","avatar":"https://static.tigerbbs.com/138d1ebc8820019726a687f0ffe45994","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":609618245,"type":1,"supId":0,"prevId":0,"content":"Like and comment pls","text":"Like and comment pls","html":"Like and comment pls"}],"langContent":"CN"},{"id":609610413,"gmtCreate":1638277496533,"gmtModify":1638277496627,"author":{"id":"3563941452424650","authorId":"3563941452424650","name":"lyokel","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3563941452424650","authorIdStr":"3563941452424650"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/609610413","repostId":2187581396,"repostType":4,"repost":{"id":"2187581396","kind":"news","pubTimestamp":1638274712,"share":"https://www.laohu8.com/m/news/2187581396?lang=&edition=full","pubTime":"2021-11-30 20:18","market":"us","language":"en","title":"JPMorgan Says Omicron Won’t Stop the Global Equities Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=2187581396","media":"Bloomberg","summary":"Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; ","content":"<ul>\n <li>Strategists expect post-Covid normalization to assert itself</li>\n <li>See 9% upside for S&amp;P 500 by end-2022; 17% for Eurozone stocks</li>\n</ul>\n<p>Omicron won’t derail the rally for global stocks, according to JPMorgan Chase &amp; Co. strategists, adding another voice to the tone of&nbsp;cautious optimism&nbsp;in the market after the recent sharp pullback.</p>\n<p>“Sporadic setbacks,” such as the emergence of omicron should be viewed “in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,” strategists led by Dubravko Lakos-Bujas and Mislav Matejka wrote in a note. “We expect post-Covid normalization to continue to assert itself globally in 2022,” they said.</p>\n<p>European and Asian stocks, along with U.S. equity futures, fell on Tuesday after&nbsp;Moderna Inc.&nbsp;executives confirmed that the omicron coronavirus variant&nbsp;could evade existing vaccines. Research is still underway to determine if the new strain is as virulent as its predecessors, while developers including Moderna, Pfizer Inc. and BioNTech SE are working on potentially updated versions of their shots.</p>\n<p><img src=\"https://static.tigerbbs.com/9fb3f6e11f7c305d036b47b9ae9eb2e5\" tg-width=\"889\" tg-height=\"501\" width=\"100%\" height=\"auto\"></p>\n<p>Unfazed by the latest scare, JPMorgan’s strategists forecast that the S&amp;P 500 Index will gain about 9% from its current levels to climb to 5,050 by end-2022. “We continue to see market upside, though more moderate, on better-than-expected earnings growth with supply shocks easing, China/EM backdrop improving, and normalizing consumer spending habits,” they wrote in their year-ahead outlook note.</p>\n<p>The strategists expect European equities to outperform U.S., Chinese stocks to fare better than emerging markets, and emerging markets to outpace developed ones.</p>\n<p>They singled out a hawkish shift by central banks, rather than Covid-19, as the key risk to their bullish outlook, while recommending that investors retain a pro-cyclical tilt, with a preference for energy and financials, consumer services, and small caps. They favor healthcare over other defensive sectors.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JPMorgan Says Omicron Won’t Stop the Global Equities Rally</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJPMorgan Says Omicron Won’t Stop the Global Equities Rally\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 20:18 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; 17% for Eurozone stocks\n\nOmicron won’t derail the rally for global stocks, according to JPMorgan ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4207":"综合性银行",".DJI":"道琼斯","BK4534":"瑞士信贷持仓","MRNA":"Moderna, Inc.",".IXIC":"NASDAQ Composite","JPM":"摩根大通",".SPX":"S&P 500 Index","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","BK4504":"桥水持仓","BK4566":"资本集团"},"source_url":"https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2187581396","content_text":"Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; 17% for Eurozone stocks\n\nOmicron won’t derail the rally for global stocks, according to JPMorgan Chase & Co. strategists, adding another voice to the tone of cautious optimism in the market after the recent sharp pullback.\n“Sporadic setbacks,” such as the emergence of omicron should be viewed “in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,” strategists led by Dubravko Lakos-Bujas and Mislav Matejka wrote in a note. “We expect post-Covid normalization to continue to assert itself globally in 2022,” they said.\nEuropean and Asian stocks, along with U.S. equity futures, fell on Tuesday after Moderna Inc. executives confirmed that the omicron coronavirus variant could evade existing vaccines. Research is still underway to determine if the new strain is as virulent as its predecessors, while developers including Moderna, Pfizer Inc. and BioNTech SE are working on potentially updated versions of their shots.\n\nUnfazed by the latest scare, JPMorgan’s strategists forecast that the S&P 500 Index will gain about 9% from its current levels to climb to 5,050 by end-2022. “We continue to see market upside, though more moderate, on better-than-expected earnings growth with supply shocks easing, China/EM backdrop improving, and normalizing consumer spending habits,” they wrote in their year-ahead outlook note.\nThe strategists expect European equities to outperform U.S., Chinese stocks to fare better than emerging markets, and emerging markets to outpace developed ones.\nThey singled out a hawkish shift by central banks, rather than Covid-19, as the key risk to their bullish outlook, while recommending that investors retain a pro-cyclical tilt, with a preference for energy and financials, consumer services, and small caps. They favor healthcare over other defensive sectors.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6785212,"gmtCreate":1638278022862,"gmtModify":1638278022893,"authorId":3582993517958198,"author":{"id":3582993517958198,"idStr":"3582993517958198","authorId":3582993517958198,"name":"Jen88","avatar":"https://static.tigerbbs.com/5aaf732b230f1241c2c9b76b2b27ae00","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":609610413,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"},{"id":6785148,"gmtCreate":1638277742753,"gmtModify":1638277742781,"authorId":3570336970209686,"author":{"id":3570336970209686,"idStr":"3570336970209686","authorId":3570336970209686,"name":"Fumiyo","avatar":"https://static.tigerbbs.com/b65de2d6a23385f374374d427d29dd42","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":609610413,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"}],"langContent":"CN"},{"id":609637124,"gmtCreate":1638277301060,"gmtModify":1638277301060,"author":{"id":"3579261515703347","authorId":"3579261515703347","name":"Catchua","avatar":"https://static.tigerbbs.com/28615a1f839b67febc33928525f76b74","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3579261515703347","authorIdStr":"3579261515703347"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/609637124","repostId":2187581396,"repostType":4,"repost":{"id":"2187581396","kind":"news","pubTimestamp":1638274712,"share":"https://www.laohu8.com/m/news/2187581396?lang=&edition=full","pubTime":"2021-11-30 20:18","market":"us","language":"en","title":"JPMorgan Says Omicron Won’t Stop the Global Equities Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=2187581396","media":"Bloomberg","summary":"Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; ","content":"<ul>\n <li>Strategists expect post-Covid normalization to assert itself</li>\n <li>See 9% upside for S&amp;P 500 by end-2022; 17% for Eurozone stocks</li>\n</ul>\n<p>Omicron won’t derail the rally for global stocks, according to JPMorgan Chase &amp; Co. strategists, adding another voice to the tone of&nbsp;cautious optimism&nbsp;in the market after the recent sharp pullback.</p>\n<p>“Sporadic setbacks,” such as the emergence of omicron should be viewed “in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,” strategists led by Dubravko Lakos-Bujas and Mislav Matejka wrote in a note. “We expect post-Covid normalization to continue to assert itself globally in 2022,” they said.</p>\n<p>European and Asian stocks, along with U.S. equity futures, fell on Tuesday after&nbsp;Moderna Inc.&nbsp;executives confirmed that the omicron coronavirus variant&nbsp;could evade existing vaccines. Research is still underway to determine if the new strain is as virulent as its predecessors, while developers including Moderna, Pfizer Inc. and BioNTech SE are working on potentially updated versions of their shots.</p>\n<p><img src=\"https://static.tigerbbs.com/9fb3f6e11f7c305d036b47b9ae9eb2e5\" tg-width=\"889\" tg-height=\"501\" width=\"100%\" height=\"auto\"></p>\n<p>Unfazed by the latest scare, JPMorgan’s strategists forecast that the S&amp;P 500 Index will gain about 9% from its current levels to climb to 5,050 by end-2022. “We continue to see market upside, though more moderate, on better-than-expected earnings growth with supply shocks easing, China/EM backdrop improving, and normalizing consumer spending habits,” they wrote in their year-ahead outlook note.</p>\n<p>The strategists expect European equities to outperform U.S., Chinese stocks to fare better than emerging markets, and emerging markets to outpace developed ones.</p>\n<p>They singled out a hawkish shift by central banks, rather than Covid-19, as the key risk to their bullish outlook, while recommending that investors retain a pro-cyclical tilt, with a preference for energy and financials, consumer services, and small caps. They favor healthcare over other defensive sectors.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JPMorgan Says Omicron Won’t Stop the Global Equities Rally</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJPMorgan Says Omicron Won’t Stop the Global Equities Rally\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 20:18 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; 17% for Eurozone stocks\n\nOmicron won’t derail the rally for global stocks, according to JPMorgan ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4207":"综合性银行",".DJI":"道琼斯","BK4534":"瑞士信贷持仓","MRNA":"Moderna, Inc.",".IXIC":"NASDAQ Composite","JPM":"摩根大通",".SPX":"S&P 500 Index","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","BK4504":"桥水持仓","BK4566":"资本集团"},"source_url":"https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2187581396","content_text":"Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; 17% for Eurozone stocks\n\nOmicron won’t derail the rally for global stocks, according to JPMorgan Chase & Co. strategists, adding another voice to the tone of cautious optimism in the market after the recent sharp pullback.\n“Sporadic setbacks,” such as the emergence of omicron should be viewed “in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,” strategists led by Dubravko Lakos-Bujas and Mislav Matejka wrote in a note. “We expect post-Covid normalization to continue to assert itself globally in 2022,” they said.\nEuropean and Asian stocks, along with U.S. equity futures, fell on Tuesday after Moderna Inc. executives confirmed that the omicron coronavirus variant could evade existing vaccines. Research is still underway to determine if the new strain is as virulent as its predecessors, while developers including Moderna, Pfizer Inc. and BioNTech SE are working on potentially updated versions of their shots.\n\nUnfazed by the latest scare, JPMorgan’s strategists forecast that the S&P 500 Index will gain about 9% from its current levels to climb to 5,050 by end-2022. “We continue to see market upside, though more moderate, on better-than-expected earnings growth with supply shocks easing, China/EM backdrop improving, and normalizing consumer spending habits,” they wrote in their year-ahead outlook note.\nThe strategists expect European equities to outperform U.S., Chinese stocks to fare better than emerging markets, and emerging markets to outpace developed ones.\nThey singled out a hawkish shift by central banks, rather than Covid-19, as the key risk to their bullish outlook, while recommending that investors retain a pro-cyclical tilt, with a preference for energy and financials, consumer services, and small caps. They favor healthcare over other defensive sectors.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6785249,"gmtCreate":1638278164432,"gmtModify":1638278164463,"authorId":3584333947690568,"author":{"id":3584333947690568,"idStr":"3584333947690568","authorId":3584333947690568,"name":"MrTig3r","avatar":"https://static.tigerbbs.com/b99cfe4b0a492018c40761a39a193aa8","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":609637124,"type":1,"supId":0,"prevId":0,"content":"<u>power</u>","text":"<u>power</u>","html":"<u>power</u>"},{"id":6785083,"gmtCreate":1638277493022,"gmtModify":1638277493056,"authorId":3563941452424650,"author":{"id":3563941452424650,"idStr":"3563941452424650","authorId":3563941452424650,"name":"lyokel","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":609637124,"type":1,"supId":0,"prevId":0,"content":"🙏","text":"🙏","html":"🙏"}],"langContent":"CN"},{"id":609635767,"gmtCreate":1638277094653,"gmtModify":1638277094754,"author":{"id":"3586853256703013","authorId":"3586853256703013","name":"aprilialand","avatar":"https://static.tigerbbs.com/ad4187787e31be179ad7d058aee6bd08","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3586853256703013","authorIdStr":"3586853256703013"},"htmlText":"sure anot","listText":"sure anot","text":"sure anot","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/609635767","repostId":2187581396,"repostType":4,"repost":{"id":"2187581396","kind":"news","pubTimestamp":1638274712,"share":"https://www.laohu8.com/m/news/2187581396?lang=&edition=full","pubTime":"2021-11-30 20:18","market":"us","language":"en","title":"JPMorgan Says Omicron Won’t Stop the Global Equities Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=2187581396","media":"Bloomberg","summary":"Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; ","content":"<ul>\n <li>Strategists expect post-Covid normalization to assert itself</li>\n <li>See 9% upside for S&amp;P 500 by end-2022; 17% for Eurozone stocks</li>\n</ul>\n<p>Omicron won’t derail the rally for global stocks, according to JPMorgan Chase &amp; Co. strategists, adding another voice to the tone of&nbsp;cautious optimism&nbsp;in the market after the recent sharp pullback.</p>\n<p>“Sporadic setbacks,” such as the emergence of omicron should be viewed “in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,” strategists led by Dubravko Lakos-Bujas and Mislav Matejka wrote in a note. “We expect post-Covid normalization to continue to assert itself globally in 2022,” they said.</p>\n<p>European and Asian stocks, along with U.S. equity futures, fell on Tuesday after&nbsp;Moderna Inc.&nbsp;executives confirmed that the omicron coronavirus variant&nbsp;could evade existing vaccines. Research is still underway to determine if the new strain is as virulent as its predecessors, while developers including Moderna, Pfizer Inc. and BioNTech SE are working on potentially updated versions of their shots.</p>\n<p><img src=\"https://static.tigerbbs.com/9fb3f6e11f7c305d036b47b9ae9eb2e5\" tg-width=\"889\" tg-height=\"501\" width=\"100%\" height=\"auto\"></p>\n<p>Unfazed by the latest scare, JPMorgan’s strategists forecast that the S&amp;P 500 Index will gain about 9% from its current levels to climb to 5,050 by end-2022. “We continue to see market upside, though more moderate, on better-than-expected earnings growth with supply shocks easing, China/EM backdrop improving, and normalizing consumer spending habits,” they wrote in their year-ahead outlook note.</p>\n<p>The strategists expect European equities to outperform U.S., Chinese stocks to fare better than emerging markets, and emerging markets to outpace developed ones.</p>\n<p>They singled out a hawkish shift by central banks, rather than Covid-19, as the key risk to their bullish outlook, while recommending that investors retain a pro-cyclical tilt, with a preference for energy and financials, consumer services, and small caps. They favor healthcare over other defensive sectors.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JPMorgan Says Omicron Won’t Stop the Global Equities Rally</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJPMorgan Says Omicron Won’t Stop the Global Equities Rally\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 20:18 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; 17% for Eurozone stocks\n\nOmicron won’t derail the rally for global stocks, according to JPMorgan ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4207":"综合性银行",".DJI":"道琼斯","BK4534":"瑞士信贷持仓","MRNA":"Moderna, Inc.",".IXIC":"NASDAQ Composite","JPM":"摩根大通",".SPX":"S&P 500 Index","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","BK4504":"桥水持仓","BK4566":"资本集团"},"source_url":"https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2187581396","content_text":"Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; 17% for Eurozone stocks\n\nOmicron won’t derail the rally for global stocks, according to JPMorgan Chase & Co. strategists, adding another voice to the tone of cautious optimism in the market after the recent sharp pullback.\n“Sporadic setbacks,” such as the emergence of omicron should be viewed “in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,” strategists led by Dubravko Lakos-Bujas and Mislav Matejka wrote in a note. “We expect post-Covid normalization to continue to assert itself globally in 2022,” they said.\nEuropean and Asian stocks, along with U.S. equity futures, fell on Tuesday after Moderna Inc. executives confirmed that the omicron coronavirus variant could evade existing vaccines. Research is still underway to determine if the new strain is as virulent as its predecessors, while developers including Moderna, Pfizer Inc. and BioNTech SE are working on potentially updated versions of their shots.\n\nUnfazed by the latest scare, JPMorgan’s strategists forecast that the S&P 500 Index will gain about 9% from its current levels to climb to 5,050 by end-2022. “We continue to see market upside, though more moderate, on better-than-expected earnings growth with supply shocks easing, China/EM backdrop improving, and normalizing consumer spending habits,” they wrote in their year-ahead outlook note.\nThe strategists expect European equities to outperform U.S., Chinese stocks to fare better than emerging markets, and emerging markets to outpace developed ones.\nThey singled out a hawkish shift by central banks, rather than Covid-19, as the key risk to their bullish outlook, while recommending that investors retain a pro-cyclical tilt, with a preference for energy and financials, consumer services, and small caps. They favor healthcare over other defensive sectors.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6785003,"gmtCreate":1638277101587,"gmtModify":1638277101615,"authorId":3586853256703013,"author":{"id":3586853256703013,"idStr":"3586853256703013","authorId":3586853256703013,"name":"aprilialand","avatar":"https://static.tigerbbs.com/ad4187787e31be179ad7d058aee6bd08","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":609635767,"type":1,"supId":0,"prevId":0,"content":"<u>following</u>","text":"<u>following</u>","html":"<u>following</u>"}],"langContent":"CN"},{"id":609638735,"gmtCreate":1638276752218,"gmtModify":1638276752548,"author":{"id":"3574334422904887","authorId":"3574334422904887","name":"Mccoy","avatar":"https://static.tigerbbs.com/44cd707075b4afce9ca1704a5c36686b","vip":1,"crmLevel":8,"crmLevelSwitch":0,"idStr":"3574334422904887","authorIdStr":"3574334422904887"},"htmlText":"Really?","listText":"Really?","text":"Really?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609638735","repostId":2187581396,"repostType":4,"repost":{"id":"2187581396","kind":"news","pubTimestamp":1638274712,"share":"https://www.laohu8.com/m/news/2187581396?lang=&edition=full","pubTime":"2021-11-30 20:18","market":"us","language":"en","title":"JPMorgan Says Omicron Won’t Stop the Global Equities Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=2187581396","media":"Bloomberg","summary":"Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; ","content":"<ul>\n <li>Strategists expect post-Covid normalization to assert itself</li>\n <li>See 9% upside for S&amp;P 500 by end-2022; 17% for Eurozone stocks</li>\n</ul>\n<p>Omicron won’t derail the rally for global stocks, according to JPMorgan Chase &amp; Co. strategists, adding another voice to the tone of&nbsp;cautious optimism&nbsp;in the market after the recent sharp pullback.</p>\n<p>“Sporadic setbacks,” such as the emergence of omicron should be viewed “in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,” strategists led by Dubravko Lakos-Bujas and Mislav Matejka wrote in a note. “We expect post-Covid normalization to continue to assert itself globally in 2022,” they said.</p>\n<p>European and Asian stocks, along with U.S. equity futures, fell on Tuesday after&nbsp;Moderna Inc.&nbsp;executives confirmed that the omicron coronavirus variant&nbsp;could evade existing vaccines. Research is still underway to determine if the new strain is as virulent as its predecessors, while developers including Moderna, Pfizer Inc. and BioNTech SE are working on potentially updated versions of their shots.</p>\n<p><img src=\"https://static.tigerbbs.com/9fb3f6e11f7c305d036b47b9ae9eb2e5\" tg-width=\"889\" tg-height=\"501\" width=\"100%\" height=\"auto\"></p>\n<p>Unfazed by the latest scare, JPMorgan’s strategists forecast that the S&amp;P 500 Index will gain about 9% from its current levels to climb to 5,050 by end-2022. “We continue to see market upside, though more moderate, on better-than-expected earnings growth with supply shocks easing, China/EM backdrop improving, and normalizing consumer spending habits,” they wrote in their year-ahead outlook note.</p>\n<p>The strategists expect European equities to outperform U.S., Chinese stocks to fare better than emerging markets, and emerging markets to outpace developed ones.</p>\n<p>They singled out a hawkish shift by central banks, rather than Covid-19, as the key risk to their bullish outlook, while recommending that investors retain a pro-cyclical tilt, with a preference for energy and financials, consumer services, and small caps. They favor healthcare over other defensive sectors.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JPMorgan Says Omicron Won’t Stop the Global Equities Rally</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJPMorgan Says Omicron Won’t Stop the Global Equities Rally\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 20:18 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; 17% for Eurozone stocks\n\nOmicron won’t derail the rally for global stocks, according to JPMorgan ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4207":"综合性银行",".DJI":"道琼斯","BK4534":"瑞士信贷持仓","MRNA":"Moderna, Inc.",".IXIC":"NASDAQ Composite","JPM":"摩根大通",".SPX":"S&P 500 Index","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","BK4504":"桥水持仓","BK4566":"资本集团"},"source_url":"https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2187581396","content_text":"Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; 17% for Eurozone stocks\n\nOmicron won’t derail the rally for global stocks, according to JPMorgan Chase & Co. strategists, adding another voice to the tone of cautious optimism in the market after the recent sharp pullback.\n“Sporadic setbacks,” such as the emergence of omicron should be viewed “in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,” strategists led by Dubravko Lakos-Bujas and Mislav Matejka wrote in a note. “We expect post-Covid normalization to continue to assert itself globally in 2022,” they said.\nEuropean and Asian stocks, along with U.S. equity futures, fell on Tuesday after Moderna Inc. executives confirmed that the omicron coronavirus variant could evade existing vaccines. Research is still underway to determine if the new strain is as virulent as its predecessors, while developers including Moderna, Pfizer Inc. and BioNTech SE are working on potentially updated versions of their shots.\n\nUnfazed by the latest scare, JPMorgan’s strategists forecast that the S&P 500 Index will gain about 9% from its current levels to climb to 5,050 by end-2022. “We continue to see market upside, though more moderate, on better-than-expected earnings growth with supply shocks easing, China/EM backdrop improving, and normalizing consumer spending habits,” they wrote in their year-ahead outlook note.\nThe strategists expect European equities to outperform U.S., Chinese stocks to fare better than emerging markets, and emerging markets to outpace developed ones.\nThey singled out a hawkish shift by central banks, rather than Covid-19, as the key risk to their bullish outlook, while recommending that investors retain a pro-cyclical tilt, with a preference for energy and financials, consumer services, and small caps. They favor healthcare over other defensive sectors.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":609639746,"gmtCreate":1638276296210,"gmtModify":1638276296311,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"4092737844653660","authorIdStr":"4092737844653660"},"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609639746","repostId":2187581396,"repostType":4,"repost":{"id":"2187581396","kind":"news","pubTimestamp":1638274712,"share":"https://www.laohu8.com/m/news/2187581396?lang=&edition=full","pubTime":"2021-11-30 20:18","market":"us","language":"en","title":"JPMorgan Says Omicron Won’t Stop the Global Equities Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=2187581396","media":"Bloomberg","summary":"Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; ","content":"<ul>\n <li>Strategists expect post-Covid normalization to assert itself</li>\n <li>See 9% upside for S&amp;P 500 by end-2022; 17% for Eurozone stocks</li>\n</ul>\n<p>Omicron won’t derail the rally for global stocks, according to JPMorgan Chase &amp; Co. strategists, adding another voice to the tone of&nbsp;cautious optimism&nbsp;in the market after the recent sharp pullback.</p>\n<p>“Sporadic setbacks,” such as the emergence of omicron should be viewed “in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,” strategists led by Dubravko Lakos-Bujas and Mislav Matejka wrote in a note. “We expect post-Covid normalization to continue to assert itself globally in 2022,” they said.</p>\n<p>European and Asian stocks, along with U.S. equity futures, fell on Tuesday after&nbsp;Moderna Inc.&nbsp;executives confirmed that the omicron coronavirus variant&nbsp;could evade existing vaccines. Research is still underway to determine if the new strain is as virulent as its predecessors, while developers including Moderna, Pfizer Inc. and BioNTech SE are working on potentially updated versions of their shots.</p>\n<p><img src=\"https://static.tigerbbs.com/9fb3f6e11f7c305d036b47b9ae9eb2e5\" tg-width=\"889\" tg-height=\"501\" width=\"100%\" height=\"auto\"></p>\n<p>Unfazed by the latest scare, JPMorgan’s strategists forecast that the S&amp;P 500 Index will gain about 9% from its current levels to climb to 5,050 by end-2022. “We continue to see market upside, though more moderate, on better-than-expected earnings growth with supply shocks easing, China/EM backdrop improving, and normalizing consumer spending habits,” they wrote in their year-ahead outlook note.</p>\n<p>The strategists expect European equities to outperform U.S., Chinese stocks to fare better than emerging markets, and emerging markets to outpace developed ones.</p>\n<p>They singled out a hawkish shift by central banks, rather than Covid-19, as the key risk to their bullish outlook, while recommending that investors retain a pro-cyclical tilt, with a preference for energy and financials, consumer services, and small caps. They favor healthcare over other defensive sectors.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JPMorgan Says Omicron Won’t Stop the Global Equities Rally</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJPMorgan Says Omicron Won’t Stop the Global Equities Rally\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 20:18 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; 17% for Eurozone stocks\n\nOmicron won’t derail the rally for global stocks, according to JPMorgan ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4207":"综合性银行",".DJI":"道琼斯","BK4534":"瑞士信贷持仓","MRNA":"Moderna, Inc.",".IXIC":"NASDAQ Composite","JPM":"摩根大通",".SPX":"S&P 500 Index","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","BK4504":"桥水持仓","BK4566":"资本集团"},"source_url":"https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2187581396","content_text":"Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; 17% for Eurozone stocks\n\nOmicron won’t derail the rally for global stocks, according to JPMorgan Chase & Co. strategists, adding another voice to the tone of cautious optimism in the market after the recent sharp pullback.\n“Sporadic setbacks,” such as the emergence of omicron should be viewed “in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,” strategists led by Dubravko Lakos-Bujas and Mislav Matejka wrote in a note. “We expect post-Covid normalization to continue to assert itself globally in 2022,” they said.\nEuropean and Asian stocks, along with U.S. equity futures, fell on Tuesday after Moderna Inc. executives confirmed that the omicron coronavirus variant could evade existing vaccines. Research is still underway to determine if the new strain is as virulent as its predecessors, while developers including Moderna, Pfizer Inc. and BioNTech SE are working on potentially updated versions of their shots.\n\nUnfazed by the latest scare, JPMorgan’s strategists forecast that the S&P 500 Index will gain about 9% from its current levels to climb to 5,050 by end-2022. “We continue to see market upside, though more moderate, on better-than-expected earnings growth with supply shocks easing, China/EM backdrop improving, and normalizing consumer spending habits,” they wrote in their year-ahead outlook note.\nThe strategists expect European equities to outperform U.S., Chinese stocks to fare better than emerging markets, and emerging markets to outpace developed ones.\nThey singled out a hawkish shift by central banks, rather than Covid-19, as the key risk to their bullish outlook, while recommending that investors retain a pro-cyclical tilt, with a preference for energy and financials, consumer services, and small caps. They favor healthcare over other defensive sectors.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":609694083,"gmtCreate":1638275619323,"gmtModify":1638275619408,"author":{"id":"4100873749187500","authorId":"4100873749187500","name":"PrimeBlue","avatar":"https://static.tigerbbs.com/7ad38f4e49566a36d2382e4e7b42a0ac","vip":1,"crmLevel":8,"crmLevelSwitch":0,"idStr":"4100873749187500","authorIdStr":"4100873749187500"},"htmlText":"Given a better understanding of the virus, there should not be as widespread lockdowns expected.Any negative news should prove to be good opportunity for swing traders&nbsp;","listText":"Given a better understanding of the virus, there should not be as widespread lockdowns expected.Any negative news should prove to be good opportunity for swing traders&nbsp;","text":"Given a better understanding of the virus, there should not be as widespread lockdowns expected.Any negative news should prove to be good opportunity for swing traders","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/609694083","repostId":2187581396,"repostType":4,"repost":{"id":"2187581396","kind":"news","pubTimestamp":1638274712,"share":"https://www.laohu8.com/m/news/2187581396?lang=&edition=full","pubTime":"2021-11-30 20:18","market":"us","language":"en","title":"JPMorgan Says Omicron Won’t Stop the Global Equities Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=2187581396","media":"Bloomberg","summary":"Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; ","content":"<ul>\n <li>Strategists expect post-Covid normalization to assert itself</li>\n <li>See 9% upside for S&amp;P 500 by end-2022; 17% for Eurozone stocks</li>\n</ul>\n<p>Omicron won’t derail the rally for global stocks, according to JPMorgan Chase &amp; Co. strategists, adding another voice to the tone of&nbsp;cautious optimism&nbsp;in the market after the recent sharp pullback.</p>\n<p>“Sporadic setbacks,” such as the emergence of omicron should be viewed “in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,” strategists led by Dubravko Lakos-Bujas and Mislav Matejka wrote in a note. “We expect post-Covid normalization to continue to assert itself globally in 2022,” they said.</p>\n<p>European and Asian stocks, along with U.S. equity futures, fell on Tuesday after&nbsp;Moderna Inc.&nbsp;executives confirmed that the omicron coronavirus variant&nbsp;could evade existing vaccines. Research is still underway to determine if the new strain is as virulent as its predecessors, while developers including Moderna, Pfizer Inc. and BioNTech SE are working on potentially updated versions of their shots.</p>\n<p><img src=\"https://static.tigerbbs.com/9fb3f6e11f7c305d036b47b9ae9eb2e5\" tg-width=\"889\" tg-height=\"501\" width=\"100%\" height=\"auto\"></p>\n<p>Unfazed by the latest scare, JPMorgan’s strategists forecast that the S&amp;P 500 Index will gain about 9% from its current levels to climb to 5,050 by end-2022. “We continue to see market upside, though more moderate, on better-than-expected earnings growth with supply shocks easing, China/EM backdrop improving, and normalizing consumer spending habits,” they wrote in their year-ahead outlook note.</p>\n<p>The strategists expect European equities to outperform U.S., Chinese stocks to fare better than emerging markets, and emerging markets to outpace developed ones.</p>\n<p>They singled out a hawkish shift by central banks, rather than Covid-19, as the key risk to their bullish outlook, while recommending that investors retain a pro-cyclical tilt, with a preference for energy and financials, consumer services, and small caps. They favor healthcare over other defensive sectors.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JPMorgan Says Omicron Won’t Stop the Global Equities Rally</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJPMorgan Says Omicron Won’t Stop the Global Equities Rally\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 20:18 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; 17% for Eurozone stocks\n\nOmicron won’t derail the rally for global stocks, according to JPMorgan ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4207":"综合性银行",".DJI":"道琼斯","BK4534":"瑞士信贷持仓","MRNA":"Moderna, Inc.",".IXIC":"NASDAQ Composite","JPM":"摩根大通",".SPX":"S&P 500 Index","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","BK4504":"桥水持仓","BK4566":"资本集团"},"source_url":"https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2187581396","content_text":"Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; 17% for Eurozone stocks\n\nOmicron won’t derail the rally for global stocks, according to JPMorgan Chase & Co. strategists, adding another voice to the tone of cautious optimism in the market after the recent sharp pullback.\n“Sporadic setbacks,” such as the emergence of omicron should be viewed “in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,” strategists led by Dubravko Lakos-Bujas and Mislav Matejka wrote in a note. “We expect post-Covid normalization to continue to assert itself globally in 2022,” they said.\nEuropean and Asian stocks, along with U.S. equity futures, fell on Tuesday after Moderna Inc. executives confirmed that the omicron coronavirus variant could evade existing vaccines. Research is still underway to determine if the new strain is as virulent as its predecessors, while developers including Moderna, Pfizer Inc. and BioNTech SE are working on potentially updated versions of their shots.\n\nUnfazed by the latest scare, JPMorgan’s strategists forecast that the S&P 500 Index will gain about 9% from its current levels to climb to 5,050 by end-2022. “We continue to see market upside, though more moderate, on better-than-expected earnings growth with supply shocks easing, China/EM backdrop improving, and normalizing consumer spending habits,” they wrote in their year-ahead outlook note.\nThe strategists expect European equities to outperform U.S., Chinese stocks to fare better than emerging markets, and emerging markets to outpace developed ones.\nThey singled out a hawkish shift by central banks, rather than Covid-19, as the key risk to their bullish outlook, while recommending that investors retain a pro-cyclical tilt, with a preference for energy and financials, consumer services, and small caps. They favor healthcare over other defensive sectors.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6784811,"gmtCreate":1638275884655,"gmtModify":1638275884686,"authorId":3586981337504184,"author":{"id":3586981337504184,"idStr":"3586981337504184","authorId":3586981337504184,"name":"wyin08","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":609694083,"type":1,"supId":0,"prevId":0,"content":"<u>yup</u>","text":"<u>yup</u>","html":"<u>yup</u>"}],"langContent":"CN"},{"id":609695464,"gmtCreate":1638275568070,"gmtModify":1638275568249,"author":{"id":"3569375896365334","authorId":"3569375896365334","name":"miaomee","avatar":"https://static.tigerbbs.com/fd309d5a46384576888494b61b0e5953","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3569375896365334","authorIdStr":"3569375896365334"},"htmlText":"Buy","listText":"Buy","text":"Buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609695464","repostId":2187581396,"repostType":4,"repost":{"id":"2187581396","kind":"news","pubTimestamp":1638274712,"share":"https://www.laohu8.com/m/news/2187581396?lang=&edition=full","pubTime":"2021-11-30 20:18","market":"us","language":"en","title":"JPMorgan Says Omicron Won’t Stop the Global Equities Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=2187581396","media":"Bloomberg","summary":"Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; ","content":"<ul>\n <li>Strategists expect post-Covid normalization to assert itself</li>\n <li>See 9% upside for S&amp;P 500 by end-2022; 17% for Eurozone stocks</li>\n</ul>\n<p>Omicron won’t derail the rally for global stocks, according to JPMorgan Chase &amp; Co. strategists, adding another voice to the tone of&nbsp;cautious optimism&nbsp;in the market after the recent sharp pullback.</p>\n<p>“Sporadic setbacks,” such as the emergence of omicron should be viewed “in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,” strategists led by Dubravko Lakos-Bujas and Mislav Matejka wrote in a note. “We expect post-Covid normalization to continue to assert itself globally in 2022,” they said.</p>\n<p>European and Asian stocks, along with U.S. equity futures, fell on Tuesday after&nbsp;Moderna Inc.&nbsp;executives confirmed that the omicron coronavirus variant&nbsp;could evade existing vaccines. Research is still underway to determine if the new strain is as virulent as its predecessors, while developers including Moderna, Pfizer Inc. and BioNTech SE are working on potentially updated versions of their shots.</p>\n<p><img src=\"https://static.tigerbbs.com/9fb3f6e11f7c305d036b47b9ae9eb2e5\" tg-width=\"889\" tg-height=\"501\" width=\"100%\" height=\"auto\"></p>\n<p>Unfazed by the latest scare, JPMorgan’s strategists forecast that the S&amp;P 500 Index will gain about 9% from its current levels to climb to 5,050 by end-2022. “We continue to see market upside, though more moderate, on better-than-expected earnings growth with supply shocks easing, China/EM backdrop improving, and normalizing consumer spending habits,” they wrote in their year-ahead outlook note.</p>\n<p>The strategists expect European equities to outperform U.S., Chinese stocks to fare better than emerging markets, and emerging markets to outpace developed ones.</p>\n<p>They singled out a hawkish shift by central banks, rather than Covid-19, as the key risk to their bullish outlook, while recommending that investors retain a pro-cyclical tilt, with a preference for energy and financials, consumer services, and small caps. They favor healthcare over other defensive sectors.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JPMorgan Says Omicron Won’t Stop the Global Equities Rally</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJPMorgan Says Omicron Won’t Stop the Global Equities Rally\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 20:18 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; 17% for Eurozone stocks\n\nOmicron won’t derail the rally for global stocks, according to JPMorgan ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4207":"综合性银行",".DJI":"道琼斯","BK4534":"瑞士信贷持仓","MRNA":"Moderna, Inc.",".IXIC":"NASDAQ Composite","JPM":"摩根大通",".SPX":"S&P 500 Index","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","BK4504":"桥水持仓","BK4566":"资本集团"},"source_url":"https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2187581396","content_text":"Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; 17% for Eurozone stocks\n\nOmicron won’t derail the rally for global stocks, according to JPMorgan Chase & Co. strategists, adding another voice to the tone of cautious optimism in the market after the recent sharp pullback.\n“Sporadic setbacks,” such as the emergence of omicron should be viewed “in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,” strategists led by Dubravko Lakos-Bujas and Mislav Matejka wrote in a note. “We expect post-Covid normalization to continue to assert itself globally in 2022,” they said.\nEuropean and Asian stocks, along with U.S. equity futures, fell on Tuesday after Moderna Inc. executives confirmed that the omicron coronavirus variant could evade existing vaccines. Research is still underway to determine if the new strain is as virulent as its predecessors, while developers including Moderna, Pfizer Inc. and BioNTech SE are working on potentially updated versions of their shots.\n\nUnfazed by the latest scare, JPMorgan’s strategists forecast that the S&P 500 Index will gain about 9% from its current levels to climb to 5,050 by end-2022. “We continue to see market upside, though more moderate, on better-than-expected earnings growth with supply shocks easing, China/EM backdrop improving, and normalizing consumer spending habits,” they wrote in their year-ahead outlook note.\nThe strategists expect European equities to outperform U.S., Chinese stocks to fare better than emerging markets, and emerging markets to outpace developed ones.\nThey singled out a hawkish shift by central banks, rather than Covid-19, as the key risk to their bullish outlook, while recommending that investors retain a pro-cyclical tilt, with a preference for energy and financials, consumer services, and small caps. They favor healthcare over other defensive sectors.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":609698167,"gmtCreate":1638275139912,"gmtModify":1638275140167,"author":{"id":"3551655093075927","authorId":"3551655093075927","name":"KLS","avatar":"https://static.tigerbbs.com/60fe00969bbce4cfecf0d17a38c77628","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3551655093075927","authorIdStr":"3551655093075927"},"htmlText":"Buy","listText":"Buy","text":"Buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609698167","repostId":2187581396,"repostType":4,"repost":{"id":"2187581396","kind":"news","pubTimestamp":1638274712,"share":"https://www.laohu8.com/m/news/2187581396?lang=&edition=full","pubTime":"2021-11-30 20:18","market":"us","language":"en","title":"JPMorgan Says Omicron Won’t Stop the Global Equities Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=2187581396","media":"Bloomberg","summary":"Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; ","content":"<ul>\n <li>Strategists expect post-Covid normalization to assert itself</li>\n <li>See 9% upside for S&amp;P 500 by end-2022; 17% for Eurozone stocks</li>\n</ul>\n<p>Omicron won’t derail the rally for global stocks, according to JPMorgan Chase &amp; Co. strategists, adding another voice to the tone of&nbsp;cautious optimism&nbsp;in the market after the recent sharp pullback.</p>\n<p>“Sporadic setbacks,” such as the emergence of omicron should be viewed “in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,” strategists led by Dubravko Lakos-Bujas and Mislav Matejka wrote in a note. “We expect post-Covid normalization to continue to assert itself globally in 2022,” they said.</p>\n<p>European and Asian stocks, along with U.S. equity futures, fell on Tuesday after&nbsp;Moderna Inc.&nbsp;executives confirmed that the omicron coronavirus variant&nbsp;could evade existing vaccines. Research is still underway to determine if the new strain is as virulent as its predecessors, while developers including Moderna, Pfizer Inc. and BioNTech SE are working on potentially updated versions of their shots.</p>\n<p><img src=\"https://static.tigerbbs.com/9fb3f6e11f7c305d036b47b9ae9eb2e5\" tg-width=\"889\" tg-height=\"501\" width=\"100%\" height=\"auto\"></p>\n<p>Unfazed by the latest scare, JPMorgan’s strategists forecast that the S&amp;P 500 Index will gain about 9% from its current levels to climb to 5,050 by end-2022. “We continue to see market upside, though more moderate, on better-than-expected earnings growth with supply shocks easing, China/EM backdrop improving, and normalizing consumer spending habits,” they wrote in their year-ahead outlook note.</p>\n<p>The strategists expect European equities to outperform U.S., Chinese stocks to fare better than emerging markets, and emerging markets to outpace developed ones.</p>\n<p>They singled out a hawkish shift by central banks, rather than Covid-19, as the key risk to their bullish outlook, while recommending that investors retain a pro-cyclical tilt, with a preference for energy and financials, consumer services, and small caps. They favor healthcare over other defensive sectors.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JPMorgan Says Omicron Won’t Stop the Global Equities Rally</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJPMorgan Says Omicron Won’t Stop the Global Equities Rally\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 20:18 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; 17% for Eurozone stocks\n\nOmicron won’t derail the rally for global stocks, according to JPMorgan ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4207":"综合性银行",".DJI":"道琼斯","BK4534":"瑞士信贷持仓","MRNA":"Moderna, Inc.",".IXIC":"NASDAQ Composite","JPM":"摩根大通",".SPX":"S&P 500 Index","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","BK4504":"桥水持仓","BK4566":"资本集团"},"source_url":"https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2187581396","content_text":"Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; 17% for Eurozone stocks\n\nOmicron won’t derail the rally for global stocks, according to JPMorgan Chase & Co. strategists, adding another voice to the tone of cautious optimism in the market after the recent sharp pullback.\n“Sporadic setbacks,” such as the emergence of omicron should be viewed “in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,” strategists led by Dubravko Lakos-Bujas and Mislav Matejka wrote in a note. “We expect post-Covid normalization to continue to assert itself globally in 2022,” they said.\nEuropean and Asian stocks, along with U.S. equity futures, fell on Tuesday after Moderna Inc. executives confirmed that the omicron coronavirus variant could evade existing vaccines. Research is still underway to determine if the new strain is as virulent as its predecessors, while developers including Moderna, Pfizer Inc. and BioNTech SE are working on potentially updated versions of their shots.\n\nUnfazed by the latest scare, JPMorgan’s strategists forecast that the S&P 500 Index will gain about 9% from its current levels to climb to 5,050 by end-2022. “We continue to see market upside, though more moderate, on better-than-expected earnings growth with supply shocks easing, China/EM backdrop improving, and normalizing consumer spending habits,” they wrote in their year-ahead outlook note.\nThe strategists expect European equities to outperform U.S., Chinese stocks to fare better than emerging markets, and emerging markets to outpace developed ones.\nThey singled out a hawkish shift by central banks, rather than Covid-19, as the key risk to their bullish outlook, while recommending that investors retain a pro-cyclical tilt, with a preference for energy and financials, consumer services, and small caps. They favor healthcare over other defensive sectors.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":76,"commentSize":12,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}